Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
Conditions
- B-Cell Chronic Lymphocytic Leukemia
- Non-Hodgkin's Lymphoma
Interventions
- DRUG: T-cell therapy + Rituximab + IL-2
Sponsor
National University Hospital, Singapore
Collaborators